Coinbase CEO’s Biotech Firm Gets $130M to Fight Aging With AI, Genomics
1 min read
NewLimit’s Series B raise adds fuel to Silicon Valley’s growing obsession with anti-aging science and biohacking immortality.
Source: Decrypt
3 min read
7 min read
1 min read
